nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—vein—testicular cancer	0.0502	0.393	CbGeAlD
Trandolapril—ACE—embryo—testicular cancer	0.00949	0.0745	CbGeAlD
Trandolapril—ACE—seminal vesicle—testicular cancer	0.00892	0.0699	CbGeAlD
Trandolapril—CES1—female gonad—testicular cancer	0.00787	0.0617	CbGeAlD
Trandolapril—SLC15A2—seminal vesicle—testicular cancer	0.00778	0.061	CbGeAlD
Trandolapril—CES1—testis—testicular cancer	0.00698	0.0547	CbGeAlD
Trandolapril—ACE—gonad—testicular cancer	0.00644	0.0505	CbGeAlD
Trandolapril—ACE—female gonad—testicular cancer	0.00524	0.0411	CbGeAlD
Trandolapril—CES1—lymph node—testicular cancer	0.00506	0.0397	CbGeAlD
Trandolapril—ACE—testis—testicular cancer	0.00464	0.0364	CbGeAlD
Trandolapril—SLC15A2—female gonad—testicular cancer	0.00457	0.0358	CbGeAlD
Trandolapril—SLC15A2—testis—testicular cancer	0.00405	0.0318	CbGeAlD
Trandolapril—ACE—lymph node—testicular cancer	0.00337	0.0264	CbGeAlD
Trandolapril—SLC15A2—lymph node—testicular cancer	0.00294	0.023	CbGeAlD
Trandolapril—Epistaxis—Epirubicin—testicular cancer	0.000699	0.000801	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—testicular cancer	0.000697	0.000799	CcSEcCtD
Trandolapril—Feeling abnormal—Etoposide—testicular cancer	0.000695	0.000797	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—testicular cancer	0.000694	0.000795	CcSEcCtD
Trandolapril—Nausea—Dactinomycin—testicular cancer	0.000692	0.000793	CcSEcCtD
Trandolapril—Agranulocytosis—Epirubicin—testicular cancer	0.000692	0.000793	CcSEcCtD
Trandolapril—Gastrointestinal pain—Etoposide—testicular cancer	0.00069	0.00079	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—testicular cancer	0.000686	0.000786	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—testicular cancer	0.000686	0.000786	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—testicular cancer	0.000686	0.000786	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—testicular cancer	0.000685	0.000785	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00068	0.000779	CcSEcCtD
Trandolapril—Vomiting—Ifosfamide—testicular cancer	0.000679	0.000778	CcSEcCtD
Trandolapril—Hypersensitivity—Cisplatin—testicular cancer	0.000678	0.000777	CcSEcCtD
Trandolapril—Bradycardia—Epirubicin—testicular cancer	0.000677	0.000776	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—testicular cancer	0.000674	0.000773	CcSEcCtD
Trandolapril—Rash—Ifosfamide—testicular cancer	0.000673	0.000772	CcSEcCtD
Trandolapril—Dermatitis—Ifosfamide—testicular cancer	0.000673	0.000771	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—testicular cancer	0.000672	0.000771	CcSEcCtD
Trandolapril—Urticaria—Etoposide—testicular cancer	0.00067	0.000768	CcSEcCtD
Trandolapril—Rhinitis—Epirubicin—testicular cancer	0.000667	0.000765	CcSEcCtD
Trandolapril—Abdominal pain—Etoposide—testicular cancer	0.000667	0.000764	CcSEcCtD
Trandolapril—Body temperature increased—Etoposide—testicular cancer	0.000667	0.000764	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—testicular cancer	0.000667	0.000764	CcSEcCtD
Trandolapril—Hepatitis—Epirubicin—testicular cancer	0.000665	0.000763	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—testicular cancer	0.000664	0.000762	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—testicular cancer	0.000663	0.00076	CcSEcCtD
Trandolapril—Asthenia—Cisplatin—testicular cancer	0.00066	0.000757	CcSEcCtD
Trandolapril—Pharyngitis—Epirubicin—testicular cancer	0.00066	0.000757	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—testicular cancer	0.00066	0.000756	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—testicular cancer	0.000657	0.000754	CcSEcCtD
Trandolapril—Urinary tract disorder—Epirubicin—testicular cancer	0.000657	0.000753	CcSEcCtD
Trandolapril—Oedema peripheral—Epirubicin—testicular cancer	0.000655	0.000751	CcSEcCtD
Trandolapril—Connective tissue disorder—Epirubicin—testicular cancer	0.000654	0.000749	CcSEcCtD
Trandolapril—Urethral disorder—Epirubicin—testicular cancer	0.000652	0.000748	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000649	0.000743	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—testicular cancer	0.000647	0.000741	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—testicular cancer	0.000645	0.000739	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—testicular cancer	0.000642	0.000736	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—testicular cancer	0.000641	0.000735	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—testicular cancer	0.000641	0.000734	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—testicular cancer	0.00064	0.000734	CcSEcCtD
Trandolapril—Nausea—Ifosfamide—testicular cancer	0.000634	0.000727	CcSEcCtD
Trandolapril—Diarrhoea—Cisplatin—testicular cancer	0.00063	0.000722	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—testicular cancer	0.000629	0.000721	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—testicular cancer	0.000628	0.00072	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—testicular cancer	0.000627	0.000718	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—testicular cancer	0.000623	0.000714	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—testicular cancer	0.000622	0.000713	CcSEcCtD
Trandolapril—Hypersensitivity—Etoposide—testicular cancer	0.000621	0.000712	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—testicular cancer	0.00062	0.000711	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—testicular cancer	0.000619	0.000709	CcSEcCtD
Trandolapril—Flushing—Epirubicin—testicular cancer	0.000618	0.000708	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—testicular cancer	0.000618	0.000708	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—testicular cancer	0.000617	0.000707	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—testicular cancer	0.000616	0.000706	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—testicular cancer	0.000611	0.0007	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—testicular cancer	0.000608	0.000697	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—testicular cancer	0.000607	0.000695	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—testicular cancer	0.000606	0.000695	CcSEcCtD
Trandolapril—Asthenia—Etoposide—testicular cancer	0.000605	0.000693	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—testicular cancer	0.000605	0.000693	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—testicular cancer	0.000604	0.000692	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—testicular cancer	0.000604	0.000692	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—testicular cancer	0.000601	0.000689	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—testicular cancer	0.0006	0.000687	CcSEcCtD
Trandolapril—Back pain—Methotrexate—testicular cancer	0.000599	0.000686	CcSEcCtD
Trandolapril—Pruritus—Etoposide—testicular cancer	0.000597	0.000684	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—testicular cancer	0.000594	0.000681	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—testicular cancer	0.000593	0.00068	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—testicular cancer	0.000588	0.000674	CcSEcCtD
Trandolapril—Vomiting—Cisplatin—testicular cancer	0.000585	0.000671	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—testicular cancer	0.000583	0.000668	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—testicular cancer	0.000582	0.000667	CcSEcCtD
Trandolapril—Rash—Cisplatin—testicular cancer	0.00058	0.000665	CcSEcCtD
Trandolapril—Dermatitis—Cisplatin—testicular cancer	0.00058	0.000665	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—testicular cancer	0.000579	0.000664	CcSEcCtD
Trandolapril—Diarrhoea—Etoposide—testicular cancer	0.000577	0.000661	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—testicular cancer	0.000575	0.000659	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—testicular cancer	0.000574	0.000658	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—testicular cancer	0.000574	0.000658	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—testicular cancer	0.000572	0.000656	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—testicular cancer	0.000571	0.000655	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—testicular cancer	0.000571	0.000655	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—testicular cancer	0.000571	0.000654	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—testicular cancer	0.000567	0.00065	CcSEcCtD
Trandolapril—Back pain—Epirubicin—testicular cancer	0.00056	0.000642	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—testicular cancer	0.000559	0.00064	CcSEcCtD
Trandolapril—Malaise—Methotrexate—testicular cancer	0.000558	0.00064	CcSEcCtD
Trandolapril—Dizziness—Etoposide—testicular cancer	0.000558	0.000639	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—testicular cancer	0.000557	0.000638	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—testicular cancer	0.000556	0.000637	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—testicular cancer	0.000556	0.000637	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—testicular cancer	0.000555	0.000636	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—testicular cancer	0.000554	0.000635	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—testicular cancer	0.00055	0.00063	CcSEcCtD
Trandolapril—Nausea—Cisplatin—testicular cancer	0.000547	0.000627	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—testicular cancer	0.000544	0.000624	CcSEcCtD
Trandolapril—Cough—Methotrexate—testicular cancer	0.00054	0.000619	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—testicular cancer	0.000539	0.000618	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—testicular cancer	0.000537	0.000616	CcSEcCtD
Trandolapril—Vomiting—Etoposide—testicular cancer	0.000536	0.000615	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—testicular cancer	0.000536	0.000614	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—testicular cancer	0.000535	0.000614	CcSEcCtD
Trandolapril—Agitation—Epirubicin—testicular cancer	0.000532	0.00061	CcSEcCtD
Trandolapril—Rash—Etoposide—testicular cancer	0.000532	0.000609	CcSEcCtD
Trandolapril—Dermatitis—Etoposide—testicular cancer	0.000531	0.000609	CcSEcCtD
Trandolapril—Headache—Etoposide—testicular cancer	0.000528	0.000606	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—testicular cancer	0.000528	0.000605	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—testicular cancer	0.000527	0.000604	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—testicular cancer	0.000527	0.000604	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—testicular cancer	0.000527	0.000604	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—testicular cancer	0.000525	0.000602	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000523	0.0006	CcSEcCtD
Trandolapril—Malaise—Epirubicin—testicular cancer	0.000522	0.000599	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—testicular cancer	0.000521	0.000597	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—testicular cancer	0.00052	0.000596	CcSEcCtD
Trandolapril—Syncope—Epirubicin—testicular cancer	0.000519	0.000595	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—testicular cancer	0.000518	0.000594	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—testicular cancer	0.000518	0.000594	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—testicular cancer	0.000515	0.000591	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—testicular cancer	0.000512	0.000587	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—testicular cancer	0.000509	0.000583	CcSEcCtD
Trandolapril—Cough—Epirubicin—testicular cancer	0.000505	0.000579	CcSEcCtD
Trandolapril—Infection—Methotrexate—testicular cancer	0.000502	0.000575	CcSEcCtD
Trandolapril—Nausea—Etoposide—testicular cancer	0.000501	0.000574	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—testicular cancer	0.000497	0.00057	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—testicular cancer	0.000495	0.000568	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—testicular cancer	0.000495	0.000568	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—testicular cancer	0.000495	0.000567	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—testicular cancer	0.000493	0.000565	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—testicular cancer	0.000493	0.000565	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—testicular cancer	0.000493	0.000565	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—testicular cancer	0.000493	0.000564	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—testicular cancer	0.000491	0.000563	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—testicular cancer	0.000491	0.000562	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00049	0.000561	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—testicular cancer	0.000488	0.00056	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—testicular cancer	0.000487	0.000558	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—testicular cancer	0.000483	0.000554	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—testicular cancer	0.000482	0.000553	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—testicular cancer	0.000482	0.000552	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—testicular cancer	0.000482	0.000552	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—testicular cancer	0.000481	0.000551	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—testicular cancer	0.00048	0.00055	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—testicular cancer	0.000474	0.000543	CcSEcCtD
Trandolapril—Oedema—Epirubicin—testicular cancer	0.000473	0.000542	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—testicular cancer	0.000472	0.000541	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—testicular cancer	0.000471	0.00054	CcSEcCtD
Trandolapril—Infection—Epirubicin—testicular cancer	0.00047	0.000538	CcSEcCtD
Trandolapril—Cough—Doxorubicin—testicular cancer	0.000468	0.000536	CcSEcCtD
Trandolapril—Shock—Epirubicin—testicular cancer	0.000465	0.000533	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—testicular cancer	0.000464	0.000531	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—testicular cancer	0.000463	0.00053	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—testicular cancer	0.000461	0.000529	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00046	0.000527	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—testicular cancer	0.000459	0.000526	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—testicular cancer	0.000457	0.000524	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—testicular cancer	0.000457	0.000524	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—testicular cancer	0.000456	0.000523	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—testicular cancer	0.000456	0.000523	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—testicular cancer	0.000456	0.000523	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—testicular cancer	0.000455	0.000521	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—testicular cancer	0.000454	0.00052	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000453	0.000519	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—testicular cancer	0.000451	0.000517	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—testicular cancer	0.000451	0.000516	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—testicular cancer	0.00045	0.000516	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—testicular cancer	0.000449	0.000515	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—testicular cancer	0.000446	0.000511	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—testicular cancer	0.000445	0.00051	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—testicular cancer	0.000442	0.000506	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—testicular cancer	0.000439	0.000503	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—testicular cancer	0.000437	0.000501	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000436	0.0005	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—testicular cancer	0.000436	0.000499	CcSEcCtD
Trandolapril—Infection—Doxorubicin—testicular cancer	0.000435	0.000498	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000431	0.000494	CcSEcCtD
Trandolapril—Shock—Doxorubicin—testicular cancer	0.00043	0.000493	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—testicular cancer	0.000429	0.000492	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—testicular cancer	0.000428	0.000491	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—testicular cancer	0.000428	0.00049	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—testicular cancer	0.000427	0.000489	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—testicular cancer	0.000425	0.000487	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—testicular cancer	0.000424	0.000487	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—testicular cancer	0.000423	0.000485	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—testicular cancer	0.000421	0.000483	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—testicular cancer	0.00042	0.000482	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—testicular cancer	0.000417	0.000478	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—testicular cancer	0.000416	0.000477	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—testicular cancer	0.000416	0.000477	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—testicular cancer	0.000413	0.000473	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—testicular cancer	0.000411	0.000471	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—testicular cancer	0.000409	0.000468	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000408	0.000468	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—testicular cancer	0.000408	0.000467	CcSEcCtD
Trandolapril—Constipation—Epirubicin—testicular cancer	0.000404	0.000463	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—testicular cancer	0.000401	0.00046	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—testicular cancer	0.000399	0.000458	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—testicular cancer	0.000399	0.000458	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000399	0.000457	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—testicular cancer	0.000396	0.000453	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—testicular cancer	0.000393	0.00045	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—testicular cancer	0.00039	0.000447	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—testicular cancer	0.00039	0.000446	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—testicular cancer	0.000389	0.000446	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—testicular cancer	0.000387	0.000443	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—testicular cancer	0.000385	0.000441	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—testicular cancer	0.00038	0.000436	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000378	0.000433	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—testicular cancer	0.000377	0.000432	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—testicular cancer	0.000376	0.00043	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—testicular cancer	0.000374	0.000429	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—testicular cancer	0.000374	0.000428	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—testicular cancer	0.000374	0.000428	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—testicular cancer	0.000372	0.000427	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—testicular cancer	0.000362	0.000415	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—testicular cancer	0.00036	0.000413	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000358	0.00041	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—testicular cancer	0.000357	0.00041	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—testicular cancer	0.000348	0.000399	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—testicular cancer	0.000347	0.000398	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—testicular cancer	0.000346	0.000396	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—testicular cancer	0.000346	0.000396	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—testicular cancer	0.000346	0.000396	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—testicular cancer	0.000339	0.000389	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—testicular cancer	0.000334	0.000383	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—testicular cancer	0.000334	0.000383	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—testicular cancer	0.000323	0.000371	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—testicular cancer	0.000322	0.000369	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—testicular cancer	0.000321	0.000368	CcSEcCtD
Trandolapril—Rash—Methotrexate—testicular cancer	0.000319	0.000365	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—testicular cancer	0.000318	0.000365	CcSEcCtD
Trandolapril—Headache—Methotrexate—testicular cancer	0.000316	0.000363	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—testicular cancer	0.000314	0.00036	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—testicular cancer	0.000313	0.000358	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—testicular cancer	0.000309	0.000355	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—testicular cancer	0.000301	0.000344	CcSEcCtD
Trandolapril—Nausea—Methotrexate—testicular cancer	0.0003	0.000344	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—testicular cancer	0.000299	0.000343	CcSEcCtD
Trandolapril—Rash—Epirubicin—testicular cancer	0.000298	0.000342	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—testicular cancer	0.000298	0.000341	CcSEcCtD
Trandolapril—Headache—Epirubicin—testicular cancer	0.000296	0.000339	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—testicular cancer	0.000289	0.000332	CcSEcCtD
Trandolapril—Nausea—Epirubicin—testicular cancer	0.000281	0.000322	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—testicular cancer	0.000278	0.000319	CcSEcCtD
Trandolapril—Rash—Doxorubicin—testicular cancer	0.000276	0.000316	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—testicular cancer	0.000276	0.000316	CcSEcCtD
Trandolapril—Headache—Doxorubicin—testicular cancer	0.000274	0.000314	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—testicular cancer	0.00026	0.000298	CcSEcCtD
